FundedIQ
Biotechnology

Trince: Funding, Investors & Team (Oct 2026)

Trince is advancing cell-based science and therapeutics by facilitating the delivery of molecules into cells, both in vitro and ex vivo.

trincebio.com LinkedIn Asse, Belgium 11-50 employees
Biopharma Biotechnology Genetics
Total raised
$6.1M
Rounds
1
Latest
Undisclosed round
Jan 2026

Trince has raised $6.1M across 1 funding round on record, the most recent an undisclosed round of $6.1M announced in Jan 2026.

That round is below the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

Trince Company Profile and Key Stats

Total funding raised
$6.1M
across 1 round on record
Funding rounds on record
1
Latest funding round
Undisclosed round
$6.1M in Jan 2026
Employees
11-50
reported band
Headquarters
Asse, Belgium

Latest funding round on record: Jan 2026.

Trince Funding Rounds

Date
Round
Amount
Undisclosed round
$6.1M

Trince Founders and Leadership Team

Name
Role
Contact
Philip Mathuis
Founder
—

No contact details are on record for this team yet.

Trince Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,185
$8.1M
303
$3.2M

Trince's latest round of $6.1M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like Trince in Biotechnology and Asse

Companies Similar to Trince

Turning biomass residues into fit-for-purpose microbial fertilizers, biostimulants and biocontrols.

Series A —

A biopharmaceutical business called Novadip Biosciences was established with the goal of creating,…

Convertible Note $11.9M

Amyl therapeutics is a preclinical-stage biotechnology company pioneering a breakthrough approach to treating…

Series A $9.6M

MAASH is a biotech mycoprotein producing company that supply a nutritious and health feed and food protein…

Seed $6.8M

Nyxoah is a health-technology company focused on the development and commercialization of innovative…

Undisclosed round $15.0M

Coultreon Biopharma is developing best-in-class therapeutics that target clinically validated pathways in…

Series A $125M

neuroClues provides easy-to-use eye-tracking environment to help practitioners instantaneously quantify their…

Series A $11.5M

Confo Therapeutics is a company focused on drug discovery, specifically targeting GPCRs to address medical…

Undisclosed round $1.2M

Animab is a biotech company that focuses on developing unique technology to enhance the health of livestock.…

Series B $11.8M

Augustine Therapeutics company is conducting two drug discovery programs in order to discover new generations…

Series A $84.1M

4Tissue is a company focused on research and clinical trials that creates remedies to address the challenges…

Seed $1.0M

Tavira Therapeutics creates an innovative platform to improve the delivery of genes using AAV. By adding…

Undisclosed round $360k

Trince Funding FAQs

What does Trince do?

Trince is advancing cell-based science and therapeutics by facilitating the delivery of molecules into cells, both in vitro and ex vivo.

How much funding has Trince raised?

Trince has raised $6.1M across 1 round on record. The most recent is an undisclosed round of $6.1M announced in Jan 2026.

When did Trince last raise funding?

Trince's most recent funding round on record is an undisclosed round of $6.1M, announced in Jan 2026.

Who founded Trince?

FundedIQ lists Philip Mathuis (Founder) at Trince.

Where is Trince headquartered?

Trince is based in Asse, Vlaams-Brabant, Belgium.

How many employees does Trince have?

Trince is in the 11-50 employee band.

How does Trince's funding compare to other Biotechnology startups?

Trince's latest round of $6.1M is below the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.

About FundedIQ's Trince Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Trince is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.

Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.